Transplantation of an obesity-associated human gut microbiota to mice induces vascular dysfunction and glucose intolerance.
Transplantation of an obesity-associated human gut microbiota to mice induces vascular dysfunction and glucose intolerance.
复制标题
DOI:
10.1080/19490976.2021.1940791
复制
发表时间:
2021-01
期刊:
影响因子:
12.2
通讯作者:
Weir TL
中科院分区:
文献类型:
--
作者:
Trikha SRJ;Lee DM;Ecton KE;Wrigley SD;Vazquez AR;Litwin NS;Thomas KN;Wei Y;Battson ML;Johnson SA;Kuhn KA;Colgan SP;Gentile CL;Weir TL
Recent preclinical data suggest that alterations in the gut microbiota may be an important factor linking obesity to vascular dysfunction, an early sign of cardiovascular disease. The purpose of this study was to begin translation of these preclinical data by examining whether vascular phenotypes in humans are transmissible through the gut microbiota. We hypothesized that germ-free mice colonized with gut microbiota from obese individuals would display diminished vascular function compared to germ-free mice receiving microbiota from lean individuals. We transplanted fecal material from obese and lean age-and sex-matched participants with disparate vascular function to germ-free mice. Using Principle Component Analysis, the microbiota of colonized mice separated by donor group along the first principle component, accounting for between 70–93% of the total variability in the dataset. The microbiota of mice receiving transplants from lean individuals was also characterized by increased alpha diversity, as well as increased relative abundance of potentially beneficial bacteria, including Bifidobacterium, Lactobacillus, and Bacteroides ovatis. Endothelium-dependent dilation, aortic pulse wave velocity and glucose tolerance were significantly altered in mice receiving microbiota from the obese donor relative to those receiving microbiota from the lean donor or those remaining germ-free. These data indicate that the obesity-associated human gut microbiota is sufficient to alter the vascular phenotype in germ-free mice in the absence of differences in body weight or dietary manipulation, and provide justification for future clinical trials to test the efficacy of microbiota-targeted therapies in the prevention or treatment of cardiovascular disease.
登录
查看更多内容
影响因子:
37.8
作者:
Go AS;Mozaffarian D;Roger VL;Benjamin EJ;Berry JD;Blaha MJ;Dai S;Ford ES;Fox CS;Franco S;Fullerton HJ;Gillespie C;Hailpern SM;Heit JA;Howard VJ;Huffman MD;Judd SE;Kissela BM;Kittner SJ;Lackland DT;Lichtman JH;Lisabeth LD;Mackey RH;Magid DJ;Marcus GM;Marelli A;Matchar DB;McGuire DK;Mohler ER 3rd;Moy CS;Mussolino ME;Neumar RW;Nichol G;Pandey DK;Paynter NP;Reeves MJ;Sorlie PD;Stein J;Towfighi A;Turan TN;Virani SS;Wong ND;Woo D;Turner MB;American Heart Association Statistics Committee and Stroke Statistics Subcommittee
通讯作者:
American Heart Association Statistics Committee and Stroke Statistics Subcommittee
DOI:
10.1038/ismej.2012.8
发表时间:
2012-08
期刊:
The ISME journal
影响因子:
--
作者:
通讯作者:
--
影响因子:
4
作者:
Farida, Eko;Nuraida, Lilis;Jenie, Betty S. L.
通讯作者:
Jenie, Betty S. L.
影响因子:
2.7
作者:
Hwang, M-H;Yoo, J-K;Christou, D. D.
通讯作者:
Christou, D. D.
影响因子:
24.5
作者:
Catry E;Bindels LB;Tailleux A;Lestavel S;Neyrinck AM;Goossens JF;Lobysheva I;Plovier H;Essaghir A;Demoulin JB;Bouzin C;Pachikian BD;Cani PD;Staels B;Dessy C;Delzenne NM
通讯作者:
Delzenne NM